Viewing Study NCT04905095


Ignite Creation Date: 2025-12-24 @ 2:13 PM
Ignite Modification Date: 2025-12-27 @ 7:00 PM
Study NCT ID: NCT04905095
Status: COMPLETED
Last Update Posted: 2025-02-12
First Post: 2021-05-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: CSAPG Early Warning Score
Sponsor: Consorci Sanitari de l'Alt Penedès i Garraf
Organization:

Study Overview

Official Title: CSAPG Early Warning Score
Status: COMPLETED
Status Verified Date: 2024-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: CEWS
Brief Summary: The Early Warning Score (EWS) has been shown in previous studies to be correlated with mortality and mean hospital stay, but it is unknown whether the implementation of the scale improves mortality and mean hospital stay.

This trial aims to study whether the implantation of the EWS in a regional hospital reduces the mean hospital stay (primary objective), mortality and complications (secondary objectives).

For this, an open clinical trial will be carried out in which the hospitalization floors of the hospital will be administratively divided into two sections (two study branches); the EWS scale will be implemented in the computer equipment of one of the sections of each floor, acting the another section as a control branch.

All the patients admitted to the participating hospital floors during one year will be included in the study. The mean stay, mortality and complications will be compared between study branches.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: